BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33225205)

  • 1. Long-term Persistence of Oral HPV Over 7 Years of Follow-up.
    D'Souza G; Clemens G; Strickler HD; Wiley DJ; Troy T; Struijk L; Gillison M; Fakhry C
    JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa047. PubMed ID: 33225205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
    Kreimer AR; Pierce Campbell CM; Lin HY; Fulp W; Papenfuss MR; Abrahamsen M; Hildesheim A; Villa LL; Salmerón JJ; Lazcano-Ponce E; Giuliano AR
    Lancet; 2013 Sep; 382(9895):877-87. PubMed ID: 23827089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years.
    D'Souza G; Tewari SR; Troy T; Webster-Cyriaque J; Wiley DJ; Lahiri CD; Palella FJ; Gillison ML; Strickler HD; Struijk L; Waterboer T; Ho K; Kwait J; Lazar J; Weber KM; Fakhry C
    Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):516-524. PubMed ID: 38294704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study.
    van Aar F; Mooij SH; van der Sande MA; Meijer CJ; King AJ; Verhagen DW; Heijman T; Coutinho RA; Schim van der Loeff MF
    BMC Infect Dis; 2014 Dec; 14():668. PubMed ID: 25551194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral human papillomavirus infection in HIV-infected and HIV-uninfected MSM: the OHMAR prospective cohort study.
    Giuliani M; Rollo F; Vescio MF; Pichi B; Latini A; Benevolo M; Pellini R; Cristaudo A; Dona' MG
    Sex Transm Infect; 2020 Nov; 96(7):528-536. PubMed ID: 32001661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of medication use with clearance or persistence of oral HPV infection.
    Lam JO; Sugar EA; Cranston RD; Weber KM; Burk RD; Wiley DJ; Reddy S; Margolick JB; Strickler HD; Wentz A; Jacobson L; Coles CL; Bream JH; Rositch AF; Guo Y; Xiao W; Gillison ML; D'Souza G
    Cancer Causes Control; 2016 Dec; 27(12):1491-1498. PubMed ID: 27804058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of anal vs oral HPV infection in HIV-infected men and women.
    Beachler DC; D'Souza G; Sugar EA; Xiao W; Gillison ML
    J Infect Dis; 2013 Jul; 208(2):330-9. PubMed ID: 23596319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
    Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
    Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
    Bettampadi D; Sirak BA; Abrahamsen ME; Reich RR; Villa LL; Ponce EL; Giuliano AR
    Clin Infect Dis; 2021 Nov; 73(9):e3227-e3234. PubMed ID: 33173937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.
    Smith-McCune KK; Shiboski S; Chirenje MZ; Magure T; Tuveson J; Ma Y; Da Costa M; Moscicki AB; Palefsky JM; Makunike-Mutasa R; Chipato T; van der Straten A; Sawaya GF
    PLoS One; 2010 Apr; 5(4):e10094. PubMed ID: 20386706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
    D'Souza G; McNeel TS; Fakhry C
    Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.
    Pierce Campbell CM; Kreimer AR; Lin HY; Fulp W; O'Keefe MT; Ingles DJ; Abrahamsen M; Villa LL; Lazcano-Ponce E; Giuliano AR
    Cancer Prev Res (Phila); 2015 Mar; 8(3):190-6. PubMed ID: 25575501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
    Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
    Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clearance of oral human papillomavirus infection: A population-based cohort study in rural China.
    Zhang C; Liu F; Pan Y; Deng Q; Li X; He Z; Liu M; Ning T; Guo C; Liang Y; Xu R; Zhang L; Cai H; Ke Y
    Oncotarget; 2017 Aug; 8(35):59831-59844. PubMed ID: 28938686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men.
    Mooij SH; Boot HJ; Speksnijder AG; Meijer CJ; King AJ; Verhagen DW; de Vries HJ; Quint WG; Molijn A; de Koning MN; van der Sande MA; van der Loeff MF
    PLoS One; 2014; 9(6):e98955. PubMed ID: 24896848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response?
    Siegel EM; Patel N; Lu B; Lee JH; Nyitray AG; Craft NE; Frenkel K; Villa LL; Franco EL; Giuliano AR
    Int J Cancer; 2012 Jul; 131(1):219-28. PubMed ID: 21858808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum cytokines with oral HPV clearance.
    Lam JO; Bream JH; Sugar EA; Coles CL; Weber KM; Burk RD; Wiley DJ; Cranston RD; Reddy S; Margolick JB; Strickler HD; Wentz A; Jacobson L; Guo Y; Xiao W; Gillison ML; D'Souza G
    Cytokine; 2016 Jul; 83():85-91. PubMed ID: 27064455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.
    D'Souza G; Gross ND; Pai SI; Haddad R; Anderson KS; Rajan S; Gerber J; Gillison ML; Posner MR
    J Clin Oncol; 2014 Aug; 32(23):2408-15. PubMed ID: 24778397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.